See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

US patients lose access to cheaper weight-loss drugs as market for replicas winds down

Summary by Financial Times
Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over

2 Articles

TodayToday
Lean Left

FDA stops sale of cheaper versions of Ozempic and Wegovy: What to do if you're taking them

Compounded Ozempic and Wegovy, cheaper generic versions of the weight-loss drugs, can no longer be sold. Doctor explains options for patients on the drugs.

·United States
Read Full Article
Financial TimesFinancial Times
Center

US patients lose access to cheaper weight-loss drugs as market for replicas winds down

Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over

·London, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Financial Times broke the news in London, United Kingdom on Tuesday, April 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Wegovy icon

Wegovy

Ozempic icon

Ozempic

United States icon

United States

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal